Julie Smith is Director of EXELIXIS, INC.. Currently has a direct ownership of 10,778 shares of EXEL, which is worth approximately $284,970. The most recent transaction as insider was on Aug 13, 2024, when has been sold 4,682 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.8K
30.28% 3M change
67.06% 12M change
Total Value Held $284,970

Julie Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 13 2024
SELL
Other acquisition or disposition
-
4,682 Reduced 30.28%
10,778 Common Stock
May 31 2024
BUY
Grant, award, or other acquisition
-
10,015 Added 39.31%
15,460 Common Stock
May 21 2024
SELL
Open market or private sale
$576,153 $21.12 p/Share
27,280 Reduced 83.36%
5,445 Common Stock
May 27 2021
BUY
Grant, award, or other acquisition
-
16,424 Added 33.42%
32,725 Common Stock

Also insider at

STOK
Stoke Therapeutics, Inc. Healthcare
JS

Julie Smith

Director
Alameda, CA

Track Institutional and Insider Activities on EXEL

Follow EXELIXIS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXEL shares.

Notify only if

Insider Trading

Get notified when an Exelixis, Inc. insider buys or sells EXEL shares.

Notify only if

News

Receive news related to EXELIXIS, INC.

Track Activities on EXEL